Literature DB >> 16887998

B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses.

Emma H Wilson1, Colby Zaph, Markus Mohrs, Andy Welcher, Jerry Siu, David Artis, Christopher A Hunter.   

Abstract

Although initial reports linked the costimulatory molecule ICOS preferentially with the development of Th2 cells, there is evidence that it is not required for protective type 2 immunity to helminths and that it contributes to Th1 and Th2 responses to other parasites. To address the role of ICOS in the development of infection-induced polarized Th cells, ICOS(-/-) mice were infected with Trichuris muris or Toxoplasma gondii. Wild-type mice challenged with T. muris developed Th2 responses and expelled these helminths by day 18 postinfection, whereas ICOS(-/-) mice failed to clear worms and produced reduced levels of type 2 cytokines. However, by day 35 postinfection, ICOS(-/-) mice were able to mount an effective Th2 response and worms were expelled. This delay in protective immunity was associated with a defect in infection-induced increases in the number of activated and proliferating CD4+ T cells. Similarly, following challenge with T. gondii ICOS was required for optimal proliferation by CD4+ T cells. However, the reduced number of activated CD4+ T cells and associated defect in the production of IFN-gamma did not result in increased susceptibility to T. gondii, but rather resulted in decreased CNS pathology during the chronic phase of this infection. Taken together, these data are consistent with a model in which ICOS is not involved in dictating polarity of the Th response but rather regulates the expansion of these subsets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887998      PMCID: PMC1780268          DOI: 10.4049/jimmunol.177.4.2365

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  ICOS is critical for CD40-mediated antibody class switching.

Authors:  A J McAdam; R J Greenwald; M A Levin; T Chernova; N Malenkovich; V Ling; G J Freeman; A H Sharpe
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

2.  A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii.

Authors:  Eric N Villegas; Linda A Lieberman; Nicola Mason; Sarah L Blass; Valerie P Zediak; Robert Peach; Tom Horan; Steve Yoshinaga; Christopher A Hunter
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

3.  IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.

Authors:  Padraic G Fallon; Helen E Jolin; Philippa Smith; Claire L Emson; Michael J Townsend; Rosie Fallon; Philip Smith; Andrew N J McKenzie
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

4.  Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis.

Authors:  Rebecca J Greenwald; Alexander J McAdam; Diane Van der Woude; Abhay R Satoskar; Arlene H Sharpe
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

5.  Trichuris muris: CD4+ T cell-mediated protection in reconstituted SCID mice.

Authors:  J Betts; M L deSchoolmeester; K J Else
Journal:  Parasitology       Date:  2000-12       Impact factor: 3.234

6.  Cutting edge: polymorphisms in the ICOS promoter region are associated with allergic sensitization and Th2 cytokine production.

Authors:  Rebecca A Shilling; Jayant M Pinto; Donna C Decker; Daniel H Schneider; Hozefa S Bandukwala; Jeffrey R Schneider; Blanca Camoretti-Mercado; Carole Ober; Anne I Sperling
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

7.  A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses.

Authors:  Yutaka Arimura; Hidehito Kato; Umberto Dianzani; Toshihiro Okamoto; Soichiro Kamekura; Donatella Buonfiglio; Tohru Miyoshi-Akiyama; Takehiko Uchiyama; Junji Yagi
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

8.  B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.

Authors:  A I Chapoval; J Ni; J S Lau; R A Wilcox; D B Flies; D Liu; H Dong; G L Sica; G Zhu; K Tamada; L Chen
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

9.  IL-10 is critical for host resistance and survival during gastrointestinal helminth infection.

Authors:  Lisa R Schopf; Karl F Hoffmann; Allen W Cheever; Joseph F Urban; Thomas A Wynn
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

10.  Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.

Authors:  Jia-Hui Yang; Jun Zhang; Qing Cai; Dang-Bao Zhao; Jian Wang; Ping-E Guo; Li Liu; Xing-Hai Han; Qian Shen
Journal:  Rheumatology (Oxford)       Date:  2005-06-29       Impact factor: 7.580

View more
  21 in total

1.  Inducible costimulator controls migration of T cells to the lungs via down-regulation of CCR7 and CD62L.

Authors:  Tamson V Moore; Bryan S Clay; Judy L Cannon; Alexander Histed; Rebecca A Shilling; Anne I Sperling
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-18       Impact factor: 6.914

2.  IL-10 and ICOS Differentially Regulate T Cell Responses in the Brain during Chronic Toxoplasma gondii Infection.

Authors:  Carleigh A O'Brien; Samantha J Batista; Katherine M Still; Tajie H Harris
Journal:  J Immunol       Date:  2019-02-04       Impact factor: 5.422

3.  Impaired dendritic cell function in a spontaneous autoimmune polyneuropathy.

Authors:  Songhua Quan; Hye-Jung Kim; Danuta Dukala; Jian Rong Sheng; Betty Soliven
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

Review 4.  The CD8 T-cell road to immunotherapy of toxoplasmosis.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

Review 5.  CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.

Authors:  SuJin Hwang; Imtiaz A Khan
Journal:  Semin Immunopathol       Date:  2015-05-06       Impact factor: 9.623

6.  T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice.

Authors:  K Olasz; F Boldizsar; K Kis-Toth; O Tarjanyi; A Hegyi; W van Eden; T A Rauch; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

7.  CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo.

Authors:  Rebecca A Shilling; Bryan S Clay; Amanda G Tesciuba; Elizabeth L Berry; Tiffany Lu; Tamson V Moore; Hozefa S Bandukwala; Jiankun Tong; Joel V Weinstock; Richard A Flavell; Tom Horan; Steve K Yoshinaga; Andrew A Welcher; Judy L Cannon; Anne I Sperling
Journal:  Cell Immunol       Date:  2009-07-10       Impact factor: 4.868

8.  ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes.

Authors:  Amanda G Tesciuba; Rebecca A Shilling; Monica D Agarwal; Hozefa S Bandukwala; Bryan S Clay; Tamson V Moore; Joel V Weinstock; Andrew A Welcher; Anne I Sperling
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

9.  Incorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity.

Authors:  Fan-ching Lin; Yue Peng; Leslie A Jones; Paulo H Verardi; Tilahun D Yilma
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

10.  The Costimulatory Molecule ICOS Regulates Host Th1 and Follicular Th Cell Differentiation in Response to Plasmodium chabaudi chabaudi AS Infection.

Authors:  Daniel J Wikenheiser; Debopam Ghosh; Brian Kennedy; Jason S Stumhofer
Journal:  J Immunol       Date:  2015-12-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.